TY - JOUR
T1 - Interleukin-6 in the central amygdala is bioactive and co-localised with glucagon-like peptide-1 receptor
AU - Anesten, Fredrik
AU - Dalmau Gasull, Adrià
AU - Richard, Jennifer E.
AU - Farkas, Imre
AU - Mishra, Devesh
AU - Taing, Lilly
AU - Zhang, Fuping
AU - Poutanen, Matti
AU - Palsdottir, Vilborg
AU - Liposits, Zsolt
AU - Skibicka, Karolina P.
AU - Jansson, John Olov
N1 - Funding Information:
We thank the Centre for Cellular Imaging at the University of Gothenburg and the National Microscopy Infrastructure, NMI (VR-RFI 2016-00968) for the use of imaging equipment. We also acknowledge support received from Julia Fernandez-Rodriguez, Maria Smedh and Carolina Tängemo. We thank the personnel at Turku Center for Disease Modeling (www.tcdm.fi) for skillful technical assistance in generating the reporter mouse line for IL-6. This work was supported by the NovoNordisk Foundation, the Swedish Research Council, the Swedish Government [under the Avtal om Läkarutbildning och Medicinsk Forskning (Agreement for Medical Education and Research)], the Knut and Alice Wallenberg Foundation, EC Framework 7, the Torsten Söderbergs Foundation (to JOJ), the Swedish Research Council (2014-2945 to KPS), the Wallenberg Foundation (to KPS), a Novo Nordisk Foundation Excellence project grant (to KPS) and the Ragnar Söderberg Foundation (KPS). The data that support the findings of this study are available from the corresponding author upon reasonable request.
Funding Information:
Ragnar SD?derbergs stiftelse; NovoNordisk Foundation; Wallenberg Foundation; Swedish Research Council, Grant/Award Number: 2014‐2945; Novo Nordisk Foundation Excellence Project Grant; Swedish Government [under the Avtal om Läkarutbildning och Medicinsk Forskning (Agreement for Medical Education and Research)]; Knut and Alice Wallenberg Foundation; EC Framework 7; Torsten SD?derbergFsoundation
Funding Information:
We thank the Centre for Cellular Imaging at the University of Gothenburg and the National Microscopy Infrastructure, NMI (VR‐RFI 2016‐00968) for the use of imaging equipment. We also acknowledge support received from Julia Fernandez‐Rodriguez, Maria Smedh and Carolina Tängemo. We thank the personnel at Turku Center for Disease Modeling (www.tcdm.fi) for skillful techni‐ cal assistance in generating the reporter mouse line for IL‐6. This work was supported by the NovoNordisk Foundation, the Swedish Research Council, the Swedish Government [under the Avtal om Läkarutbildning och Medicinsk Forskning (Agreement for Medical Education and Research)], the Knut and Alice Wallenberg Foundation, EC Framework 7, the Torsten SD?derbergFsoundation (to JOJ), the Swedish Research Council (2014‐2945 to KPS), the Wallenberg Foundation (to KPS), a Novo Nordisk Foundation Excellence project grant (to KPS) and the Ragnar SD?derbeFrgoundation (KPS). The data that support the findings of this study are available from the corre‐ sponding author upon reasonable request.
Publisher Copyright:
2019 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology
PY - 2019/6
Y1 - 2019/6
N2 - Neuronal circuits involving the central amygdala (CeA) are gaining prominence as important centres for regulation of metabolic functions. As a part of the subcortical food motivation circuitry, CeA is associated with food motivation and hunger. We have previously shown that interleukin (IL)-6 can act as a downstream mediator of the metabolic effects of glucagon-like peptide-1 (GLP-1) receptor (R) stimulation in the brain, although the sites of these effects are largely unknown. In the present study, we used the newly generated and validated RedIL6 reporter mouse strain to investigate the presence of IL-6 in the CeA, as well as possible interactions between IL-6 and GLP-1 in this nucleus. IL-6 was present in the CeA, mostly in cells in the medial and lateral parts of this structure, and a majority of IL-6-containing cells also co-expressed GLP-1R. Triple staining showed GLP-1 containing fibres co-staining with synaptophysin close to or overlapping with IL-6 containing cells. GLP-1R stimulation enhanced IL-6 mRNA levels. IL-6 receptor-alpha (IL-6Rα) was found to a large part in neuronal CeA cells. Using electrophysiology, we determined that cells with neuronal properties in the CeA could be rapidly stimulated by IL-6 administration in vitro. Moreover, microinjections of IL-6 into the CeA could slightly reduce food intake in vivo in overnight fasted rats. In conclusion, IL-6 containing cells in the CeA express GLP-1R, are close to GLP-1-containing synapses, and demonstrate increased IL-6 mRNA in response to GLP-1R agonist treatment. IL-6, in turn, exerts biological effects in the CeA, possibly via IL-6Rα present in this nucleus.
AB - Neuronal circuits involving the central amygdala (CeA) are gaining prominence as important centres for regulation of metabolic functions. As a part of the subcortical food motivation circuitry, CeA is associated with food motivation and hunger. We have previously shown that interleukin (IL)-6 can act as a downstream mediator of the metabolic effects of glucagon-like peptide-1 (GLP-1) receptor (R) stimulation in the brain, although the sites of these effects are largely unknown. In the present study, we used the newly generated and validated RedIL6 reporter mouse strain to investigate the presence of IL-6 in the CeA, as well as possible interactions between IL-6 and GLP-1 in this nucleus. IL-6 was present in the CeA, mostly in cells in the medial and lateral parts of this structure, and a majority of IL-6-containing cells also co-expressed GLP-1R. Triple staining showed GLP-1 containing fibres co-staining with synaptophysin close to or overlapping with IL-6 containing cells. GLP-1R stimulation enhanced IL-6 mRNA levels. IL-6 receptor-alpha (IL-6Rα) was found to a large part in neuronal CeA cells. Using electrophysiology, we determined that cells with neuronal properties in the CeA could be rapidly stimulated by IL-6 administration in vitro. Moreover, microinjections of IL-6 into the CeA could slightly reduce food intake in vivo in overnight fasted rats. In conclusion, IL-6 containing cells in the CeA express GLP-1R, are close to GLP-1-containing synapses, and demonstrate increased IL-6 mRNA in response to GLP-1R agonist treatment. IL-6, in turn, exerts biological effects in the CeA, possibly via IL-6Rα present in this nucleus.
UR - http://www.scopus.com/inward/record.url?scp=85066882341&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066882341&partnerID=8YFLogxK
U2 - 10.1111/jne.12722
DO - 10.1111/jne.12722
M3 - Article
C2 - 31033078
AN - SCOPUS:85066882341
SN - 0953-8194
VL - 31
JO - Journal of Neuroendocrinology
JF - Journal of Neuroendocrinology
IS - 6
M1 - e12722
ER -